Policymakers should recognise #SelfCareIsHealthcare in campaign bid to address global health challenges
July 23, 2024 19:01 ET
|
Global Self-Care Federation
The Global Self-Care Federation (GSCF) calls upon policymakers and health leaders worldwide to regard self-care as an essential component of healthcare.
Dyadic Announces Strategic Partnership Agreement to Develop Affordable Rabies Prophylactics and Vaccines Using its Proprietary C1 Cell Microbial Protein Production Platform
February 28, 2024 08:30 ET
|
Dyadic International, Inc.
JUPITER, Fla. and BUNNIK, the Netherlands, Feb. 28, 2024 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, “we”, “us”, “our”, or the “Company”) (NASDAQ: DYAI), a global biotechnology company...
Global Generic Drugs Market Size is Estimated to Reach USD 546.03 Billion by 2031, Growing at a CAGR of 4.1%: Straits Research
February 12, 2024 06:45 ET
|
Straits Research
New York, United States, Feb. 12, 2024 (GLOBE NEWSWIRE) -- Generic medications are bioequivalent to name-brand medications, meaning they have the same active components and therapeutic results....
Oral Rehydration Salts Market Size Worth USD 98.37 Million in 2032 | Emergen Research
January 18, 2024 09:15 ET
|
Emergen Research
Vancouver, Jan. 18, 2024 (GLOBE NEWSWIRE) -- The global Oral Rehydration Salts (ORS) market size was USD 69.40 Million in 2022 and is expected to register a revenue CAGR of 3.6% during the forecast...
Global fluorescein angiography market Size is Estimated to Reach USD 785.15 million by 2030, Growing at a CAGR of 5.17%: Straits Research
December 11, 2023 10:05 ET
|
Straits Research
New York, United States, Dec. 11, 2023 (GLOBE NEWSWIRE) -- Fluorescein angiography, fluorescent angiography, or fundus fluorescein angiography is a procedure that uses a fluorescent dye and a...
Dyadic Announces Top-Line Results from its Successful Phase 1 Clinical Trial for a First-in-Human Filamentous Fungal-Based Vaccine Candidate
November 29, 2023 08:30 ET
|
Dyadic International, Inc.
Dyadic Announces Top-Line Results from its Successful Phase 1 Clinical Trial for a First-in-Human Filamentous Fungal-Based Vaccine Candidate
Dyadic’s C1 Platform to be Used to Produce Vaccines for Humans and Animals in Africa
November 20, 2023 08:30 ET
|
Dyadic International, Inc.
JUPITER, Fla., Nov. 20, 2023 (GLOBE NEWSWIRE) -- Dyadic International, Inc. ("Dyadic", "we", "us", "our", or the "Company") (NASDAQ: DYAI), a global biotechnology company focused on building...
Operating Tables Market Worth Nearly $1 Billion, Globally, by 2028 - Exclusive Report by The Insight Partners
November 07, 2023 09:25 ET
|
The Insight Partners
Pune, India, Nov. 07, 2023 (GLOBE NEWSWIRE) -- Operating table is a table on which a patient lies during a surgical procedure. They are typically used within an operating room or surgical suite of a...
Lung Cancer Therapy Market Share Worth $80.49 Billion, Globally, by 2030 - Exclusive Report by The Insight Partners
November 01, 2023 06:46 ET
|
The Insight Partners
Pune, India, Nov. 01, 2023 (GLOBE NEWSWIRE) -- Lung cancer now a days is treated by targeted therapy, a type of personalized medicine, is a combination of two or more drugs, designed to directly...
Smoking Cessation Aids Market Share Worth Nearly $64 Billion, Globally, by 2028 - Exclusive Report by The Insight Partners
November 01, 2023 06:38 ET
|
The Insight Partners
Pune, India, Nov. 01, 2023 (GLOBE NEWSWIRE) -- Smoking cessation lowers the risk of cancer and other serious health problems. Some products contain nicotine as an active ingredient and others do...